MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET 2023-2030

Lifesciences | Healthcare & Wellness

MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET 2023-2030

Market by Product Type, Gender, Application, End-user, and Country Outlook | Forecast 2023-2030

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s report displays that the botulinum toxin market in the Middle East and Africa is anticipated to witness a CAGR of 10.03% during the forecasting years 2023-2030.


 Report scope can be customized per your requirements - Request Free Sample Report 

The countries evaluated in the region comprise:

•         United Arab Emirates

•         Saudi Arabia

•         Israel

•         South Africa

•         Rest of Middle East & Africa

An increasing multitude of medical professionals have commenced utilizing botulinum toxin to address an extensive array of medical ailments in the region. Its application extends to treating various dental afflictions such as bruxism, elevated lip lines, interdental gaps, and issues concerning the temporomandibular joint. The market’s appeal is on the rise, propelled by various initiatives, including brief courses centered around non-cosmetic applications and contraindications.

Saudi Arabia holds the highest share in the given region’s market. In recent years, there has been a rise in the demand for non-surgical cosmetic treatments. According to estimates, Saudi Arabia holds a significant position among the top 25 countries globally with the highest rates of cosmetic procedures. Several factors have contributed to the growth of the botulinum toxin market, including increased accessibility to aesthetic centers, a rise in consumer purchasing power, and a shift in consumer perception toward healthy aging, wellness, and beauty. These factors collectively contribute to the studied market’s progression.

Cosmetic surgery ranks among the top five medical tourism treatments, contributing to the increasing demand for cosmetic procedures in the UAE. The aesthetics sector is significant in driving medical tourism, fueled by a growing number of locally established clinics. These factors, along with a surge in demand for cosmetic treatments among the younger demographic, further open avenues for the botulinum toxin market.

While women constitute the majority of patients in aesthetic medicine, recent studies indicate a growing trend of men opting for cosmetic procedures. In 2020, approximately 8% of all cosmetic surgeries were performed on men, as reported by the American Society of Plastic Surgeons (ASPS). Although this increase might not be exponential due to its modest proportion compared to female patients, it does reveal a consistent upward trajectory. Men appear particularly inclined towards minimally invasive cosmetic treatments with minimal recovery time.

The market’s growth is determined by gender, product type, application, and end-user. The gender segment includes male and female.

The major companies in the market consist of Daewoong Pharmaceutical Co Ltd, Galderma SA, Ipsen Pharma, Hugel Inc, Candela Medical Corporation, and Merz Pharma GmbH & Co KGaA.

Merz Pharma GmbH & Co KGaA is a privately-owned pharmaceutical firm focusing on exploring, advancing, and disseminating inventive products in aesthetic medicine and movement disorders. The company encompasses various enterprises: Merz Aesthetics, Merz Therapeutics, Merz Consumer Care, Merz Real Estate, and Merz Financial Investments. Its product line includes botulinum neurotoxin, which activates the muscular system, blocking an overactive muscle. Merz’s operations span multiple regions, including the Middle East and Africa.

 

Key deliverables of the report:

·       Market CAGR during the forecasting years 2023-2030

·       Detailed data highlighting key insights, industry components, and market strategies

·       Comprehensive information and estimation of the botulinum toxin market revenue growth in the Middle East and Africa and its influence on the parent market

·       In-depth study of forthcoming trends in consumer behavioral patterns

·       A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

·       A wide-ranging study of factors that will challenge the Middle East and Africa botulinum toxin market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT ANALYSIS ON THE BOTULINUM TOXIN MARKET

2.1.1. COVID-19 IMPACT

2.2. KEY INSIGHTS

2.2.1. GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES

2.2.2. SURGE IN DEMAND FOR BOTULINUM TOXIN AMONG MILLENNIALS AND GEN-Z

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. REGULATORY FRAMEWORK

2.5. KEY MARKET STRATEGIES

2.5.1. PRODUCT LAUNCHES

2.5.2. COLLABORATIONS

2.5.3. BUSINESS EXPANSIONS & DIVESTITURES

2.5.4. ACQUISITIONS

2.6. MARKET DRIVERS

2.6.1. SURGE IN DEMAND FOR AESTHETIC PROCEDURES

2.6.2. RISE IN GERIATRIC POPULATION

2.7. MARKET CHALLENGES

2.7.1. LIMITED REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES

2.7.2. ADVERSE EFFECTS OF BOTULINUM TOXIN

2.7.3. EMERGING PROBLEM OF BOTULINUM TOXIN TYPE A RESISTANCE

2.8. MARKET OPPORTUNITIES

2.8.1. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS

2.8.2. RISING MEDICAL TOURISM

2.9. ANALYST PERSPECTIVE

3. MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET OUTLOOK - BY PRODUCT TYPE

3.1. TYPE A BOTULINUM TOXIN

3.2. TYPE B BOTULINUM TOXIN

4. MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET OUTLOOK - BY GENDER

4.1. WOMEN

4.2. MEN

5. MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET OUTLOOK - BY APPLICATION

5.1. AESTHETIC

5.1.1. CROW’S FEET

5.1.2. FOREHEAD LINES

5.1.3. FROWN LINES/GLABELLAR

5.1.4. SQUARE JAW/MASSETER

5.1.5. OTHER AESTHETIC APPLICATIONS

5.2. MEDICAL

5.2.1. CHRONIC MIGRAINE

5.2.2. MUSCLE SPASM

5.2.3. OVERACTIVE BLADDER

5.2.4. HYPERHIDROSIS

5.2.5. OTHER MEDICAL APPLICATIONS

6. MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET OUTLOOK - BY END-USER

6.1. SPECIALTY AND DERMATOLOGY CLINICS

6.2. HOSPITALS AND CLINICS

6.3. OTHER END-USERS

7. MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET – BY COUNTRY OUTLOOK

7.1. MIDDLE EAST AND AFRICA

7.1.1. MARKET BY PRODUCT TYPE

7.1.2. MARKET BY GENDER

7.1.3. MARKET BY APPLICATION

7.1.3.1. MARKET BY AESTHETIC

7.1.3.2. MARKET BY MEDICAL

7.1.4. MARKET BY END-USER

7.1.5. COUNTRY ANALYSIS

7.1.5.1. UNITED ARAB EMIRATES

7.1.5.1.1. UNITED ARAB EMIRATES BOTULINUM TOXIN MARKET FORECAST & PROSPECTS

7.1.5.2. SAUDI ARABIA

7.1.5.2.1. SAUDI ARABIA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS

7.1.5.3. ISRAEL

7.1.5.3.1. ISRAEL BOTULINUM TOXIN MARKET FORECAST & PROSPECTS

7.1.5.4. SOUTH AFRICA

7.1.5.4.1. SOUTH AFRICA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS

7.1.5.5. REST OF MIDDLE EAST & AFRICA

7.1.5.5.1. REST OF MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS

8. COMPETITIVE LANDSCAPE

8.1. ABBVIE INC

8.1.1. OVERVIEW

8.1.2. PRODUCT PORTFOLIO

8.1.3. KEY STRENGTHS

8.1.4. KEY CHALLENGES

8.2. EVOLUS INC

8.2.1. OVERVIEW

8.2.2. PRODUCT PORTFOLIO

8.2.3. KEY STRENGTHS

8.2.4. KEY CHALLENGES

8.3. MEDYTOX INC

8.3.1. OVERVIEW

8.3.2. PRODUCT PORTFOLIO

8.3.3. KEY STRENGTHS

8.3.4. KEY CHALLENGES

8.4. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD

8.4.1. OVERVIEW

8.4.2. PRODUCT PORTFOLIO

8.4.3. KEY STRENGTHS

8.4.4. KEY CHALLENGES

8.5. DAEWOONG PHARMACEUTICAL CO LTD

8.5.1. OVERVIEW

8.5.2. PRODUCT PORTFOLIO

8.5.3. KEY STRENGTHS

8.5.4. KEY CHALLENGES

8.6. GALDERMA SA

8.6.1. OVERVIEW

8.6.2. PRODUCT PORTFOLIO

8.6.3. KEY STRENGTHS

8.6.4. KEY CHALLENGES

8.7. IPSEN PHARMA

8.7.1. OVERVIEW

8.7.2. PRODUCT PORTFOLIO

8.7.3. KEY STRENGTHS

8.7.4. KEY CHALLENGES

8.8. HUGEL INC

8.8.1. OVERVIEW

8.8.2. PRODUCT PORTFOLIO

8.8.3. KEY STRENGTHS

8.8.4. KEY CHALLENGES

8.9. CANDELA MEDICAL CORPORATION

8.9.1. OVERVIEW

8.9.2. PRODUCT PORTFOLIO

8.9.3. KEY STRENGTHS

8.9.4. KEY CHALLENGES

8.10. MERZ PHARMA GMBH & CO KGAA

8.10.1. OVERVIEW

8.10.2. PRODUCT PORTFOLIO

8.10.3. KEY STRENGTHS

8.10.4. KEY CHALLENGES

8.11. REVANCE THERAPEUTICS INC

8.11.1. OVERVIEW

8.11.2. PRODUCT PORTFOLIO

8.12. US WORLDMEDS LLC

8.12.1. OVERVIEW

8.12.2. PRODUCT PORTFOLIO

9. RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.2. SOURCES OF DATA

9.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 2: MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR BOTULINUM TOXIN

TABLE 3: LIST OF PRODUCT LAUNCHES

TABLE 4: LIST OF COLLABORATIONS

TABLE 5: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

TABLE 6: LIST OF ACQUISITIONS

TABLE 7: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES

TABLE 8: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)

TABLE 9: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY GENDER, 2023-2030 (IN $ MILLION)

TABLE 10: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2023-2030 (IN $ MILLION)

TABLE 11: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)

TABLE 12: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)

TABLE 13: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY END-USER, 2023-2030 (IN $ MILLION)

TABLE 14: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

List of Figures

FIGURE 1: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)

FIGURE 2: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)

FIGURE 3: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)

FIGURE 4: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY GENDER, 2022 & 2030 (IN %)

FIGURE 5: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2030 (IN $ MILLION)

FIGURE 6: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY MEN, 2023-2030 (IN $ MILLION)

FIGURE 7: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2022 & 2030 (IN %)

FIGURE 8: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)

FIGURE 9: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2022 & 2030 (IN %)

FIGURE 10: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY CROW’S FEET, 2023-2030 (IN $ MILLION)

FIGURE 11: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2030 (IN $ MILLION)

FIGURE 12: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2030 (IN $ MILLION)

FIGURE 13: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2030 (IN $ MILLION)

FIGURE 14: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2030 (IN $ MILLION)

FIGURE 15: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)

FIGURE 16: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY MEDICAL, 2022 & 2030 (IN %)

FIGURE 17: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2030 (IN $ MILLION)

FIGURE 18: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2030 (IN $ MILLION)

FIGURE 19: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2030 (IN $ MILLION)

FIGURE 20: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2030 (IN $ MILLION)

FIGURE 21: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS, 2023-2030 (IN $ MILLION)

FIGURE 22: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY END-USER, 2022 & 2030 (IN %)

FIGURE 23: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS, 2023-2030 (IN $ MILLION)

FIGURE 24: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2030 (IN $ MILLION)

FIGURE 25: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)

FIGURE 26: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)

FIGURE 27: UNITED ARAB EMIRATES BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)

FIGURE 28: SAUDI ARABIA BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)

FIGURE 29: ISRAEL BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)

FIGURE 30: SOUTH AFRICA BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)

FIGURE 31: REST OF MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying